Liquiritin Alleviates Pain Through Inhibiting CXCL1/CXCR2 Signaling Pathway in Bone Cancer Pain Rat

• Main Authors: Huadong Ni (Author), Miao Xu (Author), Keyue Xie (Author), Yong Fei (Author), Housheng Deng (Author), Qiuli He (Author), Tingting Wang (Author), Songlei Liu (Author), Jianjun Zhu (Author), Longsheng Xu (Author), Ming Yao (Author)
• Format: Book
• Published: Frontiers Media S.A., 2020-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Bone cancer pain (BCP) is an intractable clinical problem, and lacked effective drugs for treating it. Recent research showed that several chemokines in the spinal cord are involved in the pathogenesis of BCP. In this study, the antinociceptive effects of liquiritin, which is an active component ext...